Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2
The novel coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has rapidly spread across the world. This resulted an alarming number of fatalities with millions of confirmed infected cases, pretending severe public health, economic, and social threats...
Saved in:
Main Authors: | Muhammad Bilal (Author), Hafiz M. N. Iqbal (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2
by: Syed Muhammad Ali Shah, et al.
Published: (2021) -
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
by: Ali A. Rabaan, et al.
Published: (2020) -
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
by: Mohd. Iqbal Yatoo, et al.
Published: (2020) -
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
by: Rong Xiang, et al.
Published: (2022) -
Implementation of community health care services to counter the SARS-CoV2 pandemic
by: Assunta De Luca, et al.
Published: (2024)